Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Mathematical Biosciences|May 9, 2018
Dynamical implications of bi-directional resource exchange within a meta-ecosystemMarisabel Rodriguez Messan, Darin Kopp, Daniel C Allen, et al.
Journal of Biological Dynamics|July 8, 2020
Nutritional regulation influencing colony dynamics and task allocations in social insect coloniesFeng Rao, Marisabel Rodriguez Messan, Angelica Marquez, et al.
Mathematical Biosciences|January 15, 2023
Analysis of tumor-immune functional responses in a mathematical model of neoantigen cancer vaccinesLifeng Han, Marisabel Rodriguez Messan, Osman N Yogurtcu, et al.
The AAPS Journal|April 9, 2021
A Systematic Review of the Efforts and Hindrances of Modeling and Simulation of CAR T-cell TherapyUjwani Nukala, Marisabel Rodriguez Messan, Osman N Yogurtcu, et al.
Mathematical Biosciences|March 24, 2021
Predicting the results of competition between two breast cancer lines grown in 3-D spheroid cultureMarisabel Rodriguez Messan, Mehdi Damaghi, Audrey Freischel, et al.
Mathematical Medicine and Biology : a Journal of the IMA|February 26, 2024
Dosage optimization for reducing tumor burden using a phenotype-structured population model with a drug-resistance continuumLifeng Han, Osman N Yogurtcu, Marisabel Rodriguez Messan, et al.
Plos Computational Biology|September 24, 2021
Mathematical model of a personalized neoantigen cancer vaccine and the human immune systemMarisabel Rodriguez Messan, Osman N Yogurtcu, Joseph R McGill, et al.
Plos Computational Biology|March 1, 2024
Dose optimization of an adjuvanted peptide-based personalized neoantigen melanoma vaccineWencel Valega-Mackenzie, Marisabel Rodriguez Messan, Osman N Yogurtcu, et al.
Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
A Quantitative Evaluation of COVID-19 Epidemiological ModelsOsman N Yogurtcu, Marisabel Rodriguez Messan, Richard C Gerkin, et al.
The AAPS Journal|February 9, 2023
A Retrospective Review of Center for Biologics Evaluation and Research Advisory Committee Meetings in the Context of the FDA's Benefit-Risk FrameworkJane Namangolwa Mutanga, Ujwani Nukala, Marisabel Rodriguez Messan, et al.
Pageof 1